Celadon Pharmaceuticals PLC (CEL) — Financial Flexibility Index
Celadon Pharmaceuticals PLC (CEL) has a Financial Flexibility Index of -0.21x as of June 2024. Free cash flow of GBX-1.26 Million (operating CF GBX-1.29 Million minus capex GBX29.50K) represents 0% of total liabilities (GBX6.01 Million). Check Celadon Pharmaceuticals PLC strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Celadon Pharmaceuticals PLC Financial Flexibility Index (2019–2023)
Historical Financial Flexibility Index trend for Celadon Pharmaceuticals PLC across 5 annual periods. See Celadon Pharmaceuticals PLC (CEL) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Celadon Pharmaceuticals PLC (2019–2023)
Year-by-year free cash flow to debt coverage for Celadon Pharmaceuticals PLC. For the full company profile including market capitalisation, see Celadon Pharmaceuticals PLC stock valuation.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | -0.93x | GBX-5.63 Million | GBX-5.97 Million | GBX6.04 Million | ▼ -44.3% |
| 2022 | -0.65x | GBX-4.01 Million | GBX-6.10 Million | GBX6.21 Million | ▲ +95.1% |
| 2021 | -13.21x | GBX-2.61 Million | GBX-3.15 Million | GBX197.23K | ▼ -7960.8% |
| 2020 | 0.17x | GBX630.67K | GBX-77.57K | GBX3.75 Million | ▲ +21979.9% |
| 2019 | 0.00x | GBX1.98K | GBX1.98K | GBX2.60 Million | — |